{
    "id": "924ffdf9-ce5f-4989-9a43-78a03ba3eaed",
    "indications": {
        "text": "rufinamide oral suspension indicated adjunctive treatment seizures associated lennox-gastaut syndrome pediatric patients 1 year age older adults .",
        "doid_entities": [
            {
                "text": "lennox-gastaut syndrome (DOID:0050561)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050561"
            },
            {
                "text": "syndrome (DOID:225)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_225"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "lennox-gastaut syndrome",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_2382"
            }
        ]
    },
    "contraindications": {
        "text": "rufinamide oral suspension given food . ( 2.2 ) measure oral suspension using provided adapter dosing syringe ( 2.2 ) pediatric patients 1 year older : starting daily dose : 10 mg/kg per day two equally divided doses ( 2.1 ) increase 10 mg/kg increments every day maximum dose 45 mg/kg per day , exceed 3,200 mg per day , two divided doses ( 2.1 ) adults : starting daily dose : 400 800 mg per day two equally divided doses ( 2.1 ) increase 400 800 mg every day maximum dose 3,200 mg per day , two divided doses , reached ( 2.1 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "adverseReactions": "rufinamide contraindicated patients familial short qt syndrome [ ( 5.3 ) ] .",
    "ingredients": [
        {
            "name": "RUFINAMIDE",
            "code": "WFW942PR79",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_134966"
        },
        {
            "name": "ANHYDROUS CITRIC ACID",
            "code": "XF417D3PSL",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30769"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "CARBOXYMETHYLCELLULOSE SODIUM",
            "code": "K679OBS311",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_85146"
        },
        {
            "name": "POLOXAMER 188",
            "code": "LQA7B6G8JG",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32026"
        },
        {
            "name": "METHYLPARABEN",
            "code": "A2I8C7HI9T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31835"
        },
        {
            "name": "PROPYLPARABEN",
            "code": "Z8IX2SC1OH",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32063"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "POTASSIUM SORBATE",
            "code": "1VPU26JZZ4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_77868"
        },
        {
            "name": "SORBITOL",
            "code": "506T60A25R",
            "drugbank_id": "https://go.drugbank.com/drugs/DB01638"
        },
        {
            "name": "XANTHAN GUM",
            "code": "TTV12P4NEE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_189560"
        },
        {
            "name": "ORANGE",
            "code": "5EVU04N5QU",
            "drugbank_id": "https://go.drugbank.com/drugs/DB10549"
        },
        {
            "name": "DIMETHICONE, UNSPECIFIED",
            "code": "92RU3N3Y1O",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11074"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_9661"
        }
    ],
    "organization": "Novadoz Pharmaceuticals LLC",
    "name": "Rufinamide",
    "effectiveTime": "20220102",
    "indications_original": "Rufinamide oral suspension is indicated for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older and in adults.",
    "contraindications_original": "Rufinamide oral suspension should be given with food. ( 2.2 ) Measure oral suspension using provided adapter and dosing syringe ( 2.2 ) Pediatric patients 1 year and older: Starting daily dose: 10 mg/kg per day in two equally divided doses ( 2.1 ) Increase by 10 mg/kg increments every other day to maximum dose of 45 mg/kg per day, not to exceed 3,200 mg per day, in two divided doses ( 2.1 ) Adults: Starting daily dose: 400 to 800 mg per day in two equally divided doses ( 2.1 ) Increase by 400 to 800 mg every other day until a maximum dose of 3,200 mg per day, in two divided doses, is reached ( 2.1 )",
    "adverseReactions_original": "Rufinamide is contraindicated in patients with Familial Short QT syndrome [see Warnings and Precautions (5.3)].",
    "drug": [
        {
            "name": "Rufinamide",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_134966"
        }
    ]
}